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Ileal pouch-anal anastomosis (IPAA) is the standard surgical reconstruction for patients with 
familial adenomatous polyposis (FAP) and ulcerative colitis (UC) who undergo total 
proctocolectomy (TPC). Although patients receive the same reconstruction, their postoperative 
complications can differ. We hypothesize that indication for TPC and other preoperative clinical 
factors are associated with differences in postoperative outcomes following IPAA. 
Methods 
A retrospective cohort of pediatric patients who underwent proctocolectomy with IPAA from 
1996-2016 was identified. Preoperative, operative, and postoperative clinical variables were 
collected. Univariate analyses were performed to evaluate for relevant postoperative clinical 
differences. 
Results 
Seventy-nine patients, 17 with FAP and 62 with UC, were identified. FAP patients spent a mean 
of 1125±1011 days between initial diagnosis and first surgery compared to 585±706 days by UC 
patients (p=0.038). FAP patients took a mean of 57±38 days to complete TPC with IPAA 
compared to UC patients at 177±121 days (p<0.001). FAP and UC patients did not differ in 
mean number of bowel movements at their 6-month postoperative visit [4.7±2.1 vs. 5.6±1.9, 
respectively (p=0.134)]. FAP patients were less likely to experience pouchitis (p=0.009), pouch 
failure (p<0.001), and psychiatric symptoms (p=0.019) but more likely to experience bowel 




IPAA is a safe, restorative treatment for FAP and UC patients after TPC. Based on diagnosis and 
preoperative course, there are differences in morbidity in IPAA patients. Clinical data such as 
these will allow surgeons to help families anticipate their child’s pre- and post-operative course 










































Total proctocolectomy (TPC) with ileal pouch-anal anastomosis (IPAA) is the standard 
restorative surgical treatment for patients with familial adenomatous polyposis (FAP) and 
inflammatory bowel disease (IBD), namely ulcerative colitis (UC). 1 Those diagnosed with FAP 
inevitably progress to colorectal cancer by age 50 without medical or surgical intervention. 2 3 
TPC with IPAA has been shown to effectively prevent development of colorectal cancer in FAP 
patients while maintaining fecal continence. 3 TPC with IPAA is also used to manage UC. 4 Of 
patients ultimately diagnosed with UC, 25% present during childhood or adolescence. 4 Patients 
who are diagnosed with FAP and UC during childhood often experience more severe phenotypes 
and require surgical intervention. 3 5 
Management of gastrointestinal symptoms can be taxing on pediatric patients and can 
cause psychosocial difficulties due to frequent absences from school. 5 While TPC with IPAA 
can significantly reduce cancer risk in FAP patients and debilitating symptoms in UC patients, 
postoperative outcomes are not consistent amongst patient cases. Restorative proctocolectomy 
with IPAA can be performed in either one-, two-, or three-stages (colectomy, proctectomy, then 
ileostomy takedown). 3 The number of stages performed is often determined by preoperative 
factors such as steroid use and nutritional status.   
The literature surrounding IPAA varies in its description of postoperative complication 
rates, and the association between diagnosis and postoperative outcomes are still being 
established.  One retrospective study noted that, when compared to FAP patients, UC patients 
often experienced more postoperative complications such as pouchitis. 6 This study, as with 
others in these patient populations, generally include small numbers.  Therefore, we sought to 
review all TPC with IPAA patients at Riley Hospital for Children to evaluate salient preoperative 
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factors that might predict postoperative clinical outcome.  We hypothesize that indication for 
TPC with IPAA, amongst other preoperative clinical factors, are associated with relevant 
differences in surgical timing and postoperative outcomes. 
Methods 
Subjects 
Patients who underwent TPC with IPAA at Riley Hospital for Children from 1996-2016 were 
identified using a search of the electronic medical record for the following CPT codes: 45119 
Proctectomy, combined abdominoperineal pull-through procedure (eg, colo-anal anastomosis), 
with creation of colonic reservoir (eg, J-pouch), with diverting enterostomy when performed, 
45113 Proctectomy, partial, with rectal mucosectomy, ileoanal anastomosis, creation of ileal 
reservoir (S or J), with or without loop ileostomy, 45397 Laparoscopy, surgical; proctectomy, 
combined abdominoperineal pull-through procedure (eg, colo-anal anastomosis), with creation of 
colonic reservoir (eg, J-pouch), with diverting enterostomy, when performed, 44158 Colectomy, 
total, abdominal, with proctectomy; with ileoanal anastomosis, creation of ileal reservoir (S or J), 
includes loop ileostomy, and rectal mucosectomy, when performed, and 44211 Laparoscopy, 
surgical; colectomy, total, abdominal, with proctectomy, with ileoanal anastomosis, creation of 
ileal reservoir (S or J), with loop ileostomy, includes rectal mucosectomy, when performed. 
Patients who underwent the above procedures were also identified through manual review of 
Riley Hospital for Children weekly Morbidity and Mortality records.  
Definitions of Outcome Variables 
Pouch leak: evidence of leakage due to anastomotic incompetence either clinically (purulent 
intra-abdominal fluid found on diagnostic laparoscopy) or by imaging (contrast enema or CT 
scan demonstrating leak). 
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Superficial surgical site infection: any postoperative wound that required opening for drainage 
and/or oral antibiotic treatment for incisional erythema. 
Deep abscess: was defined as an intra-abdominal abscess that required operative or percutaneous 
drainage. 
Pouch failure: any pouch requiring operative revision or resection. 
Pouchitis: clinical symptoms of pouch inflammation requiring oral antibiotic treatment or 
evidence of pouch inflammation found on diagnostic endoscopy done in response to symptoms 
Bowel Obstruction: clinical symptoms and imaging signs of bowel obstruction requiring enteric 
decompression and/or operation for bowel obstruction.  
Incontinence: soiling due to fecal incontinence uncontrolled by commonly used anti-diarrheals 
such as loperamide or diphenoxylate. 
Bloody bowel movement: patient reported blood while wiping after bowel movement. 
Postoperative anastomotic stricture at IPAA: patient with clinical symptoms of stricture that 
required formal dilation in the operating room. 
Psychiatric symptoms: depression, anxiety, social aversion, suicidality, and stress noted by 
surgeons in their postoperative follow-up.   
Relevant preoperative, operative, and postoperative clinical variables were collected.  
Institutional Review Board approval was obtained and an wavier of consent was obtained.   
Statistical Analysis 
Continuous variables were described as mean values with standard deviations or median with 
interquartile ranges. Univariate analyses with Chi-square, Fisher’s exact test, or Wilcoxon-Rank 
Sum tests were performed to evaluate for relevant clinical differences in outcome. Statistical 
Revised 
significance was set at 0.05.  All statistical analyses were carried out with Stata version 14 
(College Station, TX). 
 
Results 
A total of 80 patients were identified from the search.  Seventeen patients were diagnosed 
with FAP, and 62 were diagnosed with UC. Patients diagnosed with indeterminate colitis (n=1) 
were excluded. Seventy-nine pediatric patients who underwent IPAA were analyzed. The 
demographics and important preoperative clinic factors are listed in Table 1. Table 2 shows 
postoperative outcomes for both FAP and UC patients. Preoperatively, UC patients had more 
frequent abdominal pain (p<0.001), more preoperative hospitalizations (p=0.002), and lower 
albumin (p<0.001) than FAP patients. FAP and UC patients did not differ in their mean 
preoperative hemoglobin (p=0.136).  
 Table 2 shows time from initial diagnosis, either FAP or UC, to first surgery (stage 1 of 
TPC with IPAA). FAP patients spent a mean of 1125 (±1011) days between initial diagnosis and 
first surgery compared to 585 (±706) days by UC patients (p=0.038). Furthermore, FAP patients 
took significantly less time from first surgery to IPAA completion (completion of all planned 
procedures) with a mean of 57 (±38) days compared to UC patients at 177 (±121) days 
(p<0.001).  FAP patients were more likely to undergo one- or two-stage procedures compared to 
UC patients, who were more likely to undergo two- or three-stage procedures (p<0.001). Within 
the UC patient population, there was no association between use of biologic therapy and number 
of stages (p=0.302).  UC patients were more likely to have open proctectomy (33%) whereas 
FAP patients were more likely to have laparoscopic proctectomy (86%) (p=0.046). FAP and UC 
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patients did not differ in their anastomosis type (hand-sewn vs. stapled) (p=0.804) nor their 
incidence of intraoperative complications (p=0.465). 
 At their first postoperative visit, FAP and UC patients did not differ in mean number of 
bowel movements [4.3±2.3 vs. 6.1±3.9, respectively (p=0.083)]. In addition, FAP and UC 
patients also did not differ in mean number of bowel movements at their 6-month postoperative 
visit [4.7±2.1 vs. 5.6±1.9, respectively (p=0.134)]. Postoperatively, FAP patients are 
significantly less likely to experience pouchitis (p=0.009), pouch failure (p=<0.001), and 
psychiatric symptoms (p=0.019), but more likely to experience bowel obstruction (p=0.002) 
(Table 2).  Bowel obstruction in FAP patients were due to ileostomy torsion (n=2), adhesions 
(n=2) and unknown etiology (n=3).  Bowel obstructions in UC patients were due to adhesions 
(n=6) and stoma stenosis (n=1). Furthermore, UC patients were more likely to be prescribed anti-
motility agents (88.9%) than FAP patients (66.7%) (p=0.017). However, there was no significant 
difference in daily anti-motility agent use between UC patients (74.1% used daily, 11.1% used as 
needed, and 14.8% did not use) and FAP patients (41.7% use daily, 16.7% used as needed, and 
41.7% did not use) (p=0.069). Within the UC group, preoperative steroid use was associated with 
superficial surgical infection (p=0.049) but not associated with pouchitis (p=0.872). 
Furthermore, we found no association between use of laparoscopy and bowel obstruction 
(p=0.39). Analysis performed on each disease group revealed no association between use of 
laparoscopy and bowel obstruction within FAP patients (p=0.92) and UC patients (p=0.96).  The 






IPAA is the standard restorative procedure after TPC for both FAP and UC.  We 
hypothesized that, while the surgical technique is similar in both patient populations, significant 
postoperative differences would be noted based on the indication for surgery. In this 
retrospective cohort study, we identified several differences and additionally quantified the 
differences in timing of surgery in both of these groups.  Ultimately, we believe that, in 
understanding how these populations differ, surgeons will be well positioned to provide 
anticipatory guidance to patients and their families.      
The most common complication following IPAA in patients with UC in our study was 
pouchitis (49%).  This rate is consistent with other studies in this area. Lillehei and colleagues 
found UC patients had a 47% rate of at least one episode after IPAA. 6 They note, as do we, very 
low rates of pouchitis after IPAA for FAP. 6 Interestingly, Diederen et al noted 22% of their 
pediatric population with pouchitis postoperatively.  A minority of these patients (5%) had 
chronic pouchitis. 7 The differences in pouchitis rates are most likely related to the definition of 
pouchitis utilized in each study.  We utilized a more clinically-oriented definition by including 
those episodes which required antibiotic therapy.  Other possible pouchitis definitions may focus 
on more objective endoscopic and/or pathologic criteria.  As other authors have noted, the rate of 
pouchitis following IPAA for UC is most likely related to the generalized pro-inflammatory 
nature of UC.     
FAP patients were also less likely to experience pouch failure, psychiatric symptoms, and 
daily anti-motility agent use postoperatively compared to UC patients. Although psychiatric 
symptom was listed as a postoperative outcome because of more detailed postoperative note 
taking in our study, it is likely that psychiatric symptoms were present preoperatively, possibly 
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related to stress related to managing flare-ups in UC patients. Our results agreed with Ozdemir et 
al, which demonstrated less frequent sepsis (FAP vs UC, 10.3% vs 10.9%), pouchitis (17.6% vs 
35.7%), and pouch failure (5.9% vs 8.5%) in FAP vs UC patients. 1 In accordance with our data, 
Lovegrove et al also found that FAP patients were less likely to experience pouchitis (5.5%) 
compared to UC patients (30.1%). 8 
In this study, UC patients had a more complicated preoperative course than FAP patients 
and were more likely to experience abdominal pain, be hospitalized, and have lower albumin 
levels. These data are expected given the symptomatic course of UC which may include severe 
bleeding, diarrhea, obstruction, perforation, and toxic megacolon even with biologic 
intervention. 1 In comparison, FAP patients sometimes experience rectal bleeding from colonic 
adenomas, however, many patients are asymptomatic until progression to colorectal cancer in 
adulthood. 2 3 Because most of the literature focuses on postoperative outcomes, preoperative 
data on IPAA is sparse. Families can expect more preoperative events if their child has UC as 
opposed to FAP. Furthermore, preoperative use of steroids without tapering was associated with 
postoperative superficial surgical infection and suggests that patients should be tapered off 
steroids before surgery if able. 
Analysis of patients’ timeline to surgery revealed that FAP patients spent more time from 
diagnosis to first surgery (1125±1011 days compared to 585±706 days) but less time from first 
surgery to procedure completion when compared to UC patients (57±38 days to 177±121 days). 
Because of their long asymptomatic period, FAP patients expectedly undergo a longer 
observational period before their first surgery. In comparison, UC patients may experience 
complications such as refractory colitis or fulminant colitis and require urgent or even emergent 
colectomy. 9 10 Furthermore, the emergent nature of some colectomies as well as preoperative 
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deconditioning and malnutrition in some UC patients necessitates two- or three- stage procedures 
thus lengthens the time from first surgery to IPAA completion. The outcome measures, “time 
from diagnosis to first surgery” and “time from first surgery to IPAA completion,” are important 
tools that can help visualize and anticipate an IPAA patient’s clinical course. 
Analysis of postoperative outcomes demonstrate that FAP and UC patients did not differ 
in their mean number of bowel movements at neither their first postoperative visit (4.3 vs 6.1, 
respectively) nor their six-month postoperative visit (4.7 vs 5.6, respectively).  Similarly, 
Ozdemir et al found no difference in mean daily bowel movements between FAP (5.4±4.4) and 
UC (5.3±2.6) patients. 1 However, Fazio et al demonstrated a difference in mean daily bowel 
movements at 1-year post-operation (FAP 6 and UC 7), but no difference in mean daily bowel 
movements at 5 years or 10 years post-operation. 11 In addition, we demonstrate that UC patients 
(88.9%) were more likely to be prescribed anti-motility agents compared to FAP patients 
(66.7%) but that there is no significant difference in anti-motility agent use between UC and FAP 
patients. The data offer a snapshot of anti-motility use 1-month post-operation whereas 
Michelassi et al demonstrate a decrease in anti-motility agent use over time for UC patients. 12 
Our data suggest that many physicians may anticipate worse incontinence in UC patients 
compared to FAP patients when there may be no significant difference in bowel function after 
IPAA. Bowel function is a common concern for IPAA patients, and it is important for families 
and patients to be counseled on the expected number of postoperative daily bowel movements.  
 Interestingly, the data show that FAP patients were more likely to experience bowel 
obstruction. This differs from the literature where Ozdemir et al demonstrates no significance in 
obstruction rates between FAP (29.4%) and UC (16.6%) patients.1  The FAP patients in this 
study experienced obstruction due to torsion of the ileostomy as well as from adhesions; 
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comparatively bowel obstructions in UC patients were universally secondary to adhesions. 
However, long term risk of small bowel obstruction is a well-described phenomenon.  In a cross-
sectional study by MacLean and colleagues, 44% of their postoperative small bowel obstruction 
patients occurred within 30 days of their operation and 5.2% required laparotomy. 13   Many of 
the postoperative bowel obstructions in our series were also in the immediate postoperative 
period.  We do not have an explanation for the increased frequency of obstruction in FAP 
patients; however, many of these patients were performed in only 1 or 2 stages as opposed to the 
3-stage procedure in UC.  Whether this results in less intra-abdominal adhesions and an 
increased predilection for internal hernia or torsion around the ileostomy site is not known. 
This study has several limitations.  It is a retrospective study of a complex patient cohort 
and therefore suffers from being limited by the data present in the patient’s chart.  Many of these 
patients, given their age, transition to providers at other institutions potentially creates missing 
data.  Specifically, our data may underestimate postoperative episodes of pouchitis, pouch failure 
and small bowel obstruction. Paper charts were accessed for patients receiving procedures prior 
to 2008. Compared to electronic records, paper charts were more limited in their documentation 
and length of follow up. Furthermore, although several of our patients stay within the health 
system, allowing us to access their records several years after their operation, postoperative 
complications could be missing due to patients moving out of state or accessing hospitals outside 
of the IU health system. Given the sample size, and relatively small outcome variables, we were 
unable to perform multivariate analyses which may have been beneficial to clarify the strength of 
association between outcome variables and indication for IPAA. 
TPC with IPAA is a safe operative approach for patients with UC and FAP.  However, it 
can be associated with significant morbidity, which can significantly alter a patient’s, and their 
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family’s life, postoperatively. Given increased knowledge of the postoperative course after 
complex, many times multi-step, surgical interventions, patients and their families can better 
organize the logistics of care and minimize the potential anxiety that can come with major 
surgery. This study further contributes to the understanding of the postoperative course after TPC 
in light of both the indication for the procedure as well as other tangible preoperative clinical 
factors. These data allow for clinicians and surgeons to provide improved anticipatory guidance 
to this patient population. 
Conclusion 
 In summary, this study demonstrates significant differences between preoperative, 
operative, and postoperative outcomes between UC and FAP patients. Measures such as “time 
from diagnosis to first surgery” and “time from first surgery to IPAA completion” are important 
data that allow surgeons to help families anticipate their child’s pre- and post-operative course 
and to maximize successful clinical outcomes. 
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Table 1 
IPAA Patient Demographic and Preoperative Data 
 
Values are provided in n (%) and mean (± standard deviation). 
*Median with interquartile range. 
Demographics FAP UC p Value 
Male 11 (65%) 31 (50%)  
Female 6 (35%) 31 (50%)  
Race 
White 13 (76%) 48 (77%)  
African American 2 (12%) 12 (19%)  
Asian 2 (12%) 2 (3%)  
Age* 14.5 (12.2-15.8) 14.9 (12.3-16.4) NS 
Preoperative 
Complications 
   
 
# Experiencing Abdominal 
Pain 
3 (23%) 39 (80%) <0.001 
Average Hospitalizations 
One Year Preop 
0 0.75 ±0.12 0.002 
Average Albumin 4.4 ± 0.1 3.20 ±0.13 <0.001 
Average Hemoglobin 12.57 ±0.45 10.92 ± 0.61 0.136 
Table 2 
 




FAP UC p Value 






Average Days from Stage I to 
IPAA completion 57±38 (n=14) 177±21 (n=53) <0.001 
Postoperative Complications    
Pouch Leak 0 2 (4%) 0.498 
Superficial Surgical Infection 1 (9%) 6 (12%) 0.814 
Deep Abscess 1 (8%) 3 (6%) 0.728 
Pouch Failure 0 2 (4%) <0.001 
Pouchitis 1 (8%) 27 (49%) 0.009 
Bowel Obstruction 7 (54%) 7 (13%) 0.002 
Incontinence 0 10 (19%) 0.106 
Anastomotic stricture 1 (5.9%) 8 (12.9%) 0.481 
Bloody Bowel Movement 3 (25%) 13 (24%) 0.946 
Psychiatric Symptoms 0 9 (17%) 0.019 
 
Postoperative Values are provided in n (%). 
 
